GILEAD SCIENCES INC (GILD:NASDAQ)
$153.54 5.62 (3.7994%)
Analysed GILEAD SCIENCES INC (GILD:NASDAQ) News Sources
Gilead Sciences (GILD) Laps the Stock Market: Here's Why
09-10-2026
yahoo.com
Why Is Everyone Ignoring Gilead Stock's High Cash Yield?
10-10-2026
trefis.com
Is Gilead Sciences (GILD) Undervalued After Strong Q2 Sales?
11-10-2026
yahoo.com
Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?
11-10-2026
yahoo.com
Can Gilead (GILD) Stock Continue Rising in 2027?
12-10-2026
yahoo.com
Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says
12-10-2026
yahoo.com
Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?
13-10-2026
yahoo.com
Earnings Preview: What to Expect From Gilead Sciences’ Report
13-10-2026
barchart.com
Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
14-10-2026
yahoo.com
What Does Gilead Sciences (GILD) Gain From Its New Solid Tumor Partnership?
14-10-2026
yahoo.com
What is the current price of GILEAD SCIENCES INC (GILD:NASDAQ)?
The current price of GILEAD SCIENCES INC (GILD:NASDAQ) is $153.54.
GILEAD SCIENCES INC (GILD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is $5.62.
GILEAD SCIENCES INC (GILD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is 3.7994%.
What is the most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent sentiment for GILEAD SCIENCES INC (GILD:NASDAQ) is .
SEC-8K** Filing Available For GILEAD SCIENCES INC (GILD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.